Evaluation of the Role of Local Steroid Injection in Treatment of Idiopathic Spasmodic Flat Foot in Adolescent Patients

Study Overview
=================
Brief Summary
-----------------
Population: adolescent patients aged from 10 to 16 years Interventions: Examination under general anaesthesia if the deformity corrected spontaneously local injection of steroid in sinus tarsi cast in varus for 6 weeks Outcomes: primary outcome : Evaluate the clinical and functional outcomes according AOFAS. Time: follow up within one and half month, 3 months, 6 months, one year.

Detailed Description
-----------------
• Does local steroid injection have a role in treatment of spasmodic flat foot in adolescent patients? One of the most common foot complaints in the juvenile and adolescent age group is the flatfoot deformity. (1) Clinical evaluation of flatfeet primarily focuses on differentiation between the two main types: flexible and rigid. (2) The flexible type is a common diagnosis and is one which is usually not problematic and rarely needs treatment. (3) Rigid flatfoot deformity is less common (occurring one-third as often as the flexible type) but often is symptomatic and requires treatment. (4) Spasmodic valgus foot is usually associated with resistant pain and deformity. It shows controversy regarding its incidence, etiology, and treatment. (5) Spasmodic flatfoot is a rare condition characterized by a rigid and usually painful valgus deformity in the hind foot with peroneal muscles spasms (6,7) It is often caused by inter-tarsal bars or bone anomalies that restrict tarsal joint motion . (8) Our study aims to evaluate the functional and clinical outcome after local long-acting steroid injection in the sinus tarsi followed by cast in adolescent patients with spasmodic flatfeet without coalition.

Official Title
-----------------
Evaluation of the Role of Local Steroid Injection in Treatment of Idiopathic Spasmodic Flat Foot in Adolescent Patients

Conditions
-----------------
Flatfoot

Intervention / Treatment
-----------------
* Drug: Triamcinolone Injection


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Age of the patients from 10 to 16 years Flat foot with peroneal muscle spasm Exclusion Criteria: Flatfoot uncorrected by manipulation under general anaesthesia neuromuscular disorders evidence of coalition in CT or MRI

Ages Eligible for Study
-----------------
Minimum Age: 10 Years
Maximum Age: 16 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: spasmotic flatfoot patient<br> | Drug: Triamcinolone Injection<br>* local injection in sinus tarsi<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Evaluate the functional outcomes according AOFAS Ankle-hindfoot scale |  | 45days |